Nature Cancer
ISSN: 2662-1347
Publisher: Springer Nature
Publications (7)
Spatially resolved transcriptomics and graph-based deep learning improve accuracy of routine CNS tumor diagnostics (2025)
Ritter M, Blume C, Tang Y, Patel A, Patel B, Berghaus N, Kada Benotmane J, et al.
Journal article
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome (2024)
Vinnakota JM, Biavasco F, Schwabenland M, Chhatbar C, Adams RC, Erny D, Duquesne S, et al.
Journal article
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma (2023)
Váraljai R, Zimmer L, Al-Matary Y, Kaptein P, Albrecht LJ, Shannan B, Brase JC, et al.
Journal article
Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma (Nature Cancer, (2023), 4, 9, (1292-1308), 10.1038/s43018-023-00610-2) (2023)
Váraljai R, Zimmer L, Al-Matary Y, Kaptein P, Albrecht LJ, Shannan B, Brase JC, et al.
Journal article, Erratum
Zooming in on dendritic cells for CD40 agonists (2022)
Hübner J, Nimmerjahn F
Journal article
Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas (2021)
Friedrich M, Sankowski R, Bunse L, Kilian M, Green E, Ramallo Guevara C, Pusch S, et al.
Journal article
Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia (2021)
Lu J, Cannizzaro E, Meier-Abt F, Scheinost S, Bruch PM, Giles HAR, Lutge A, et al.
Journal article